Biotech · Private company
Coeptis Therapeutics
Track this companyFree. Adds Coeptis Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- DVX201Phase 1 · AML, Adult RecurrentClinicalTrials.gov · fetched Nov 12, 2026
- DVX201Phase 1 · COVID-19 PneumoniaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDSPHASE1 · COMPLETED · started Dec 15, 2021ClinicalTrials.gov NCT04901416 · fetched Nov 12, 2026
- Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19PHASE1 · COMPLETED · started Aug 1, 2021ClinicalTrials.gov NCT04900454 · fetched Nov 12, 2026